This topic contains a solution. Click here to go to the answer

Author Question: A regulated monopoly facing average cost pricing rule will make the same profit as a firm in ... (Read 134 times)

Jipu 123

  • Hero Member
  • *****
  • Posts: 569
A regulated monopoly facing average cost pricing rule will make the same profit as a firm in ________ market does in the long run.
 
  A) an unregulated monopoly
  B) an oligopoly
  C) a perfectly competitive
  D) All of the above answers are correct.

Question 2

You are studying with a friend and your friend says A budget line shows the various combinations of two goods that can be purchased with the buyer's income at current prices. Is your friend's assessment correct or not?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

peter

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

C

Answer to Question 2

Your friend's description of the budget line is accurate.




Jipu 123

  • Member
  • Posts: 569
Reply 2 on: Jun 29, 2018
:D TYSM


chereeb

  • Member
  • Posts: 326
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library